Table 3.
Number of detected mutations.
| Mutation | Number | Percent |
|---|---|---|
| ABL1 | 1 | 1.0% |
| AKT1 | 1 | 1.0% |
| ALK | 1 | 1.0% |
| APC | 1 | 1.0% |
| ARID1A | 1 | 1.0% |
| ATM | 4 | 3.9% |
| ATR | 2 | 1.9% |
| BAP1 | 1 | 1.0% |
| BRAF | 3 | 2.9% |
| BRCA1 | 1 | 1.0% |
| BRCA2 | 1 | 1.0% |
| CCND3 | 1 | 1.0% |
| CDKN1B | 1 | 1.0% |
| CDKN2A | 3 | 2.9% |
| CREBBP | 2 | 1.9% |
| EGFR | 3 | 2.9% |
| ERBB4 | 1 | 1.0% |
| FGFR1 | 1 | 1.0% |
| FGFR3 | 1 | 1.0% |
| FGFR4 | 2 | 1.9% |
| GNAQ | 1 | 1.0% |
| IDH1 | 10 | 9.7% |
| IGF1R | 1 | 1.0% |
| IDH2 | 1 | 1.0% |
| KDR | 2 | 1.9% |
| MAF | 1 | 1.0% |
| MLH1 | 2 | 1.9% |
| MRE11A | 1 | 1.0% |
| MTOR | 1 | 1.0% |
| NF1 | 1 | 1.0% |
| NOTCH1 | 2 | 1.9% |
| PDGFRA | 1 | 1.0% |
| PIK3CA | 7 | 6.8% |
| PIK3CB | 1 | 1.0% |
| PIK3R1 | 2 | 1.9% |
| POLE | 3 | 2.9% |
| PTCH | 1 | 1.0% |
| PTEN | 1 | 1.0% |
| PTPN11 | 2 | 1.9% |
| RAD51C | 1 | 1.0% |
| RB1 | 2 | 1.9% |
| RET | 1 | 1.0% |
| SLX4 | 1 | 1.0% |
| SMAD4 | 2 | 1.9% |
| SMARCB1 | 1 | 1.0% |
| SMO | 2 | 1.9% |
| STK11 | 2 | 1.9% |
| TERT | 1 | 1.0% |
| TP53 | 15 | 14.6% |
| TSC2 | 1 | 1.0% |
| VHL | 1 | 1.0% |
| Total | 103 | 100% |